Ionis’ $500M offering; Terns aims to raise $125M

Plus, news about Chai Discovery, Relay Therapeutics, Incannex Healthcare, PhoreMost, Epsilogen and LIFTT:

Ionis prices $500M offering: The veteran RNA biotech is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA to decide on Sanofi/Regeneron’s Dupixent for COPD in June – Pharmaceutical Technology

Share this article Dupixent is approved by the FDA in five indications namely atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis and prurigo

February 23, 2024

Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia

Use of the BRAF inhibitor vemurafenib (Zelboraf) combined with the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) led to high rates of complete remission as frontline therapy

September 26, 2023

Exclusive: After CureVac, Igor Splawski moves to RTW stealth startup; Lyndra’s Jessica Ballinger adds CEO title amid commercial prep

A chunky chain necklace, matching earrings, and a floral shirt with a dozen colors — that’s Igor Splawski. The former chief scientist at CureVac has

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.